Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast
He predicted the 2020 crash a month before it happened…He predicted this year’s collapse back in January…

And now, he’s issuing a brand-new warning – along with a unique solution.
Details here.
Stephen Gordon net worth and biography

Stephen Gordon Biography and Net Worth

Stephen Gordon joined TransMedics in March of 2015 and leads our finance and accounting team. He has over 20 years of experience leading financial organizations within high technology and medical device companies.  During this time his areas of focus have been strategic planning, M&A integration, financial planning and analysis, and improvement in the presentation of quantitative information. Prior to joining TransMedics, Mr. Gordon was the Vice President, Financial Planning & Analysis at Analogic Corporation, a medical device and security technology company. Before joining Analogic, Mr. Gordon held various financial leadership positions at Hologic, Cytyc, Maxtor and Hewlett-Packard. Mr. Gordon earned a Bachelor’s degree in Finance and Accounting from The Wharton School at The University of Pennsylvania, and an MBA from Boston University.

What is Stephen Gordon's net worth?

The estimated net worth of Stephen Gordon is at least $238,159.52 as of July 5th, 2022. Mr. Gordon owns 5,714 shares of TransMedics Group stock worth more than $238,160 as of September 26th. This net worth approximation does not reflect any other assets that Mr. Gordon may own. Additionally, Mr. Gordon receives a salary of $529,320.00 as CFO at TransMedics Group. Learn More about Stephen Gordon's net worth.

How old is Stephen Gordon?

Mr. Gordon is currently 54 years old. There are 2 older executives and no younger executives at TransMedics Group. The oldest executive at TransMedics Group is Mr. John F. Carey, VP of Operations, who is 57 years old. Learn More on Stephen Gordon's age.

What is Stephen Gordon's salary?

As the CFO of TransMedics Group, Inc., Mr. Gordon earned a total compensation package of $1,969,497.00 in 2021. Mr. Gordon earned a salary of $370,800.00, options awards of $1,440,180.00, non-equity compensation of $158,517.00, and no other miscellaneous compensation. There are 2 executives that earn more than Mr. Gordon. The highest earning executive at TransMedics Group is Dr. Waleed H. Hassanein M.D., Founder, Pres, MD, CEO & Director, who commands a salary of $992,420.00 per year. Learn More on Stephen Gordon's salary.

How do I contact Stephen Gordon?

The corporate mailing address for Mr. Gordon and other TransMedics Group executives is 200 MINUTEMAN ROAD SUITE 302, ANDOVER MA, 01810. TransMedics Group can also be reached via phone at (978) 552-0900 and via email at [email protected] Learn More on Stephen Gordon's contact information.

Has Stephen Gordon been buying or selling shares of TransMedics Group?

During the last ninety days, Stephen Gordon has sold $350,000.00 in TransMedics Group stock. Most recently, Stephen Gordon sold 10,000 shares of the business's stock in a transaction on Tuesday, July 5th. The shares were sold at an average price of $35.00, for a transaction totalling $350,000.00. Following the completion of the sale, the chief financial officer now directly owns 5,714 shares of the company's stock, valued at $199,990. Learn More on Stephen Gordon's trading history.

Who are TransMedics Group's active insiders?

TransMedics Group's insider roster includes John Carey (VP), Stephen Gordon (CFO), Waleed Hassanein (CEO), Edwin Kania, Jr. (Director), and Tamer Khayal (Insider). Learn More on TransMedics Group's active insiders.

Are insiders buying or selling shares of TransMedics Group?

In the last year, TransMedics Group insiders bought shares 1 times. They purchased a total of 100,000 shares worth more than $2,256,000.00. In the last year, insiders at the sold shares 22 times. They sold a total of 244,781 shares worth more than $9,028,190.48. The most recent insider tranaction occured on September, 7th when CEO Waleed H Hassanein sold 2,277 shares worth more than $125,235.00. Insiders at TransMedics Group own 8.7 % of the company. Learn More about insider trades at TransMedics Group.

Information on this page was last updated on 9/7/2022.

Stephen Gordon Insider Trading History at TransMedics Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/5/2022Sell10,000$35.00$350,000.005,714View SEC Filing Icon  
9/7/2021Sell10,000$35.00$350,000.0015,714View SEC Filing Icon  
7/15/2021Sell10,000$35.00$350,000.0015,714View SEC Filing Icon  
6/17/2021Sell10,000$30.00$300,000.0010,000View SEC Filing Icon  
3/15/2021Sell10,000$39.81$398,100.0010,000View SEC Filing Icon  
2/16/2021Sell10,000$31.33$313,300.0010,000View SEC Filing Icon  
2/8/2021Sell10,000$25.01$250,100.00View SEC Filing Icon  
4/27/2020Sell9,900$18.00$178,200.0018,571View SEC Filing Icon  
4/22/2020Sell100$18.00$1,800.0028,471View SEC Filing Icon  
See Full Table

Stephen Gordon Buying and Selling Activity at TransMedics Group

This chart shows Stephen Gordon's buying and selling at TransMedics Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TransMedics Group Company Overview

TransMedics Group logo
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Read More

Today's Range

Now: $41.68
Low: $40.83
High: $42.61

50 Day Range

MA: $45.92
Low: $32.21
High: $55.75

2 Week Range

Now: $41.68
Low: $10.00
High: $56.41


459,000 shs

Average Volume

316,848 shs

Market Capitalization

$1.17 billion

P/E Ratio


Dividend Yield